Responder analysis of keishibukuryogan for the symptoms of Yusho certified patients

Author:

Kainuma Mosaburo1ORCID,Nakahara Takeshi23,Tsuji Gaku23

Affiliation:

1. Department of Japanese Oriental Medicine, Graduate school of Medicine and Pharmaceutical Sciences University of Toyama Toyama Japan

2. Research and Clinical Center for Yusho and Dioxin Kyushu University Hospital Fukuoka Japan

3. Department of Dermatology, Graduate School of Medical Sciences Kyushu University Fukuoka Japan

Abstract

AbstractBackgroundYusho is a 1968 mass food poisoning that was caused by the ingestion of rice oil contaminated with dioxins and related organochlorines. We previously reported that keishibukuryogan (KBG) administration was effective for improvement of the symptoms of Yusho patients. This study used responder analysis to more deeply elucidate the effectiveness of KBG.MethodThe data analyzed in the study were collected from our previous clinical study done to predict response to KBG treatment. The patients were divided into responders and non‐responders based on whether their symptoms improved after taking KBG. We assessed baseline patient characteristics and the intensity of general fatigue and dermatological, neurological, and respiratory symptoms. Further, we used SF‐36 to evaluate Quality of Life (QOL).ResultsOf the 42 patients who completed the previous study, 27 were responders and 15 non‐responders, with no significant differences in the patient characteristics. The general fatigue, dermatological symptoms, and respiratory symptoms of responders were significantly improved at month 3 of treatment. Analysis of the eight QOL domain profiles of SF‐36 showed that the general health of responders was significantly improved from baseline to month 3 compared with non‐responders, as was vitality from baseline to month 1. Moreover, the mental health of responders significantly improved from baseline to months 1 and 3.ConclusionsKeishibukuryogan was not only effective for symptoms such as general fatigue, dermatological symptoms, and respiratory symptoms, but also for the mental health of Yusho patients, which indicates that it would be a good first‐choice Kampo medicine for the treatment of these patients.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3